Related Experiment Video

Updated: May 27, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

An update on direct genotoxicity as a molecular mechanism of ochratoxin a carcinogenicity

Annie Pfohl-Leszkowicz1, Richard A Manderville

  • 1Laboratoire de Génie Chimique , UMR CNRS/INPT/UPS 5503, INP/ENSA Toulouse, 1 Avenue Agrobiopole, F-31326 Auzeville-Tolosane, France. leszkowicz@ensat.fr

Chemical Research in Toxicology
|November 8, 2011
PubMed

Insights

Ochratoxin A (OTA) is a fungal toxin that contaminates food and poses a cancer risk. New evidence strengthens the argument for direct genotoxicity, specifically DNA adduction, as the mechanism of action for OTA-induced kidney cancer in humans.

Area of Science:

  • Toxicology
  • Carcinogenesis
  • Molecular Biology

Background:

  • Ochratoxin A (OTA) is a widespread fungal toxin found in food products.
  • OTA is a suspected human carcinogen, particularly linked to kidney cancer.
  • The precise mechanism of action (MOA) for OTA's carcinogenicity, especially renal carcinogenicity, remains debated.

Purpose of the Study:

  • To review and synthesize recent findings on the MOA of OTA-mediated renal carcinogenicity.
  • To evaluate the evidence for direct genotoxicity, including DNA adduction, as a key MOA.
  • To provide an updated perspective on OTA's carcinogenic pathway for human risk assessment.

Main Methods:

  • Review of published literature from the past 6-7 years concerning OTA toxicity and genotoxicity.
  • Analysis of findings from key research laboratories (Umemura and Nohmi) on OTA mutagenicity in target tissues.
  • Examination of new structural evidence for OTA-DNA adduct formation.

Main Results:

  • Recent studies provide definitive evidence for OTA mutagenicity in the male rat kidney's outer medulla.
  • These findings exclude oxidative DNA damage as the primary mechanism.
  • New structural data support the formation of OTA-DNA adducts, strengthening the direct genotoxicity hypothesis.

Conclusions:

  • Direct genotoxicity, specifically DNA adduction, is increasingly supported as the MOA for OTA-induced renal carcinogenesis.
  • This MOA is crucial for accurate human risk assessment of Ochratoxin A exposure.
  • Further research should focus on the implications of direct genotoxicity in OTA's carcinogenic effects.

More Related Videos

Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter12:15

Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter

Published on: May 29, 2019

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.